What is a common adverse reaction of sotagliflozin?
•
4 min read
Clinical trial data from meta-analyses have consistently highlighted genitourinary infections as a frequent adverse event associated with sotagliflozin, a dual SGLT1/SGLT2 inhibitor. This, along with other reactions like diarrhea and volume depletion, is a direct consequence of the drug's unique dual-inhibition mechanism.
